Caption Management, LLC Trevi Therapeutics, Inc. Transaction History
Caption Management, LLC
- $8.03 Billion
- Q2 2025
A detailed history of Caption Management, LLC transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 367,600 shares of TRVI stock, worth $4.23 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
367,600Holding current value
$4.23 Million% of portfolio
0.03%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding TRVI
# of Institutions
167Shares Held
111MCall Options Held
1.07MPut Options Held
425K-
Nea Management Company, LLC Timonium, MD13.2MShares$152 Million6.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.3MShares$118 Million2.96% of portfolio
-
Rubric Capital Management LP New York, NY8.53MShares$98.3 Million1.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.32MShares$61.2 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA4.49MShares$51.7 Million5.2% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $672M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...